tiprankstipranks
Advertisement
Advertisement

OSTX Stock Latest News

Jason McCarthy Initiates Buy on OS Therapies, Citing Advancing OST-HER2 Program, Key Regulatory Catalysts, and Strengthened Cash Runway Into 2027
RatingsJason McCarthy Initiates Buy on OS Therapies, Citing Advancing OST-HER2 Program, Key Regulatory Catalysts, and Strengthened Cash Runway Into 2027
3d ago
OSTX
OS Therapies Launches $75 Million At-The-Market Offering
PremiumCompany Announcements
OS Therapies Launches $75 Million At-The-Market Offering
5d ago
8K
OSTX
OS Therapies Announces Convertible Note Financing and Warrants
PremiumCompany Announcements
OS Therapies Announces Convertible Note Financing and Warrants
14d ago
8K
OSTX
OS Therapies Settles Leonite Debt, Issues Bridge Financing
PremiumCompany Announcements
OS Therapies Settles Leonite Debt, Issues Bridge Financing
20d ago
8K
OSTX
OS Therapies Ends At-The-Market Equity Sales Program
PremiumCompany Announcements
OS Therapies Ends At-The-Market Equity Sales Program
28d ago
8K
OSTX
OS Therapies terminates At Market Issuance Sales Agreement
PremiumThe FlyOS Therapies terminates At Market Issuance Sales Agreement
28d ago
OSTX
OS Therapies initiated with a Buy at Roth Capital
Premium
The Fly
OS Therapies initiated with a Buy at Roth Capital
2M ago
OSTX
OS Therapies Secures Convertible Note Financing for Expansion
Premium
Company Announcements
OS Therapies Secures Convertible Note Financing for Expansion
2M ago
8K
OSTX
OS Therapies price target lowered to $13 from $14 at Lake Street
PremiumThe Fly
OS Therapies price target lowered to $13 from $14 at Lake Street
3M ago
OSTX
OS Therapies Delays Quarterly SEC Filing
PremiumCompany Announcements
OS Therapies Delays Quarterly SEC Filing
3M ago
OSTX
OS Therapies Gains EMA Rolling Review for OST-HER2
PremiumCompany Announcements
OS Therapies Gains EMA Rolling Review for OST-HER2
4M ago
8K
OSTX
OSTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OSTX Earnings this Week: How Will it Perform?
5M ago
OSTX
OS Therapies bolsters funding to advance OST-HER2 program
PremiumCompany AnnouncementsOS Therapies bolsters funding to advance OST-HER2 program
5M ago
8K
OSTX
Regulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
Premium
Ratings
Regulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
5M ago
OSTX
OS Therapies price target lowered to $14 from $17 at Lake Street
Premium
The Fly
OS Therapies price target lowered to $14 from $17 at Lake Street
5M ago
OSTX
OS Therapies Files Prospectus Supplement for Share Resale
PremiumCompany Announcements
OS Therapies Files Prospectus Supplement for Share Resale
5M ago
8K
OSTX
OS Therapies Raises $2 Million via Convertible Notes
PremiumCompany Announcements
OS Therapies Raises $2 Million via Convertible Notes
6M ago
8K
OSTX
OS Therapies Extends Warrant Inducement Offering Period
PremiumCompany Announcements
OS Therapies Extends Warrant Inducement Offering Period
6M ago
8K
OSTX
OS Therapies Raises Capital Through Warrant Inducement Agreements
PremiumCompany Announcements
OS Therapies Raises Capital Through Warrant Inducement Agreements
8M ago
8K
OSTX
Promising Outlook for OS Therapies: Buy Rating Backed by Positive FDA Meeting and Strategic Positioning
PremiumRatingsPromising Outlook for OS Therapies: Buy Rating Backed by Positive FDA Meeting and Strategic Positioning
8M ago
OSTX
OS Therapies price target lowered to $17 from $18 at Lake Street
Premium
The Fly
OS Therapies price target lowered to $17 from $18 at Lake Street
9M ago
OSTX
OS Therapies Reports Increased Losses Amid Rising R&D Costs
Premium
Company Announcements
OS Therapies Reports Increased Losses Amid Rising R&D Costs
9M ago
OSTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >